Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Structure-activity relationships for a class of selective inhibitors of the major cysteine protease from Trypanosoma cruzi

Texto completo
Autor(es):
Guido, Rafael V. C. [1] ; Trossini, Gustavo H. G. [2] ; Castilho, Marcelo S. [3] ; Oliva, Glaucius [1] ; Ferreira, Elizabeth I. [2] ; Andricopulo, Adriano D. [1]
Número total de Autores: 6
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Inst Fis Sao Carlos, Ctr Biotecnol Mol Estrutural, Lab Quim Med & Computac, BR-13560970 Sao Carlos, SP - Brazil
[2] Univ Sao Paulo, Fac Ciencias Farmaceut, Lab Planejamento & Sintese Quimioterap Potenciais, BR-05508900 Sao Paulo - Brazil
[3] Univ Fed Bahia, Fac Farm, Lab Bioinformat & Modelagem Mol, BR-40170290 Salvador, BA - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo Científico
Fonte: Journal of Enzyme Inhibition and Medicinal Chemistry; v. 23, n. 6, p. 964-973, 2008.
Área do conhecimento: Ciências da Saúde - Farmácia
Citações Web of Science: 26
Assunto(s):Química farmacêutica   Terapêutica   Doença de Chagas   Trypanosoma cruzi   Inibidores enzimáticos
Resumo

Chagas' disease is a parasitic infection widely distributed throughout Latin America, with devastating consequences in terms of human morbidity and mortality. Cruzain, the major cysteine protease from Trypanosoma cruzi, is an attractive target for antitrypanosomal chemotherapy. In the present work, classical two-dimensional quantitative structure-activity relationships (2D QSAR) and hologram QSAR (HQSAR) studies were performed on a training set of 45 thiosemicarbazone and semicarbazone derivatives as inhibitors of T. cruzi cruzain. Significant statistical models (HQSAR, q2 = 0.75 and r2 = 0.96; classical QSAR, q2 = 0.72 and r2 = 0.83) were obtained, indicating their consistency for untested compounds. The models were then used to evaluate an external test set containing 10 compounds which were not included in the training set, and the predicted values were in good agreement with the experimental results (HQSAR, = 0.95; classical QSAR, = 0.91), indicating the existence of complementary between the two ligand-based drug design techniques. (AU)

Processo FAPESP: 01/01192-3 - Antichagásicos potenciais derivados de compostos nitro-heterocíclicos
Beneficiário:Elizabeth Igne Ferreira
Linha de fomento: Auxílio à Pesquisa - Temático